DK0789583T3 - Fremgangsmåder og kits som anvender makrofagstimulerende protein - Google Patents
Fremgangsmåder og kits som anvender makrofagstimulerende proteinInfo
- Publication number
- DK0789583T3 DK0789583T3 DK95937641T DK95937641T DK0789583T3 DK 0789583 T3 DK0789583 T3 DK 0789583T3 DK 95937641 T DK95937641 T DK 95937641T DK 95937641 T DK95937641 T DK 95937641T DK 0789583 T3 DK0789583 T3 DK 0789583T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- msp
- kits
- stimulating protein
- macrophage stimulating
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000049853 macrophage stimulating protein Human genes 0.000 title abstract 2
- 108010053292 macrophage stimulating protein Proteins 0.000 title abstract 2
- 102100032813 Hepatocyte growth factor-like protein Human genes 0.000 abstract 4
- 210000001772 blood platelet Anatomy 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 230000035800 maturation Effects 0.000 abstract 2
- 210000003593 megakaryocyte Anatomy 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 206010043554 thrombocytopenia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/334,177 US5696086A (en) | 1994-11-03 | 1994-11-03 | Methods and kits using macrophage stimulating protein |
| PCT/US1995/013830 WO1996014082A1 (en) | 1994-11-03 | 1995-10-25 | Methods and kits using macrophage stimulating protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0789583T3 true DK0789583T3 (da) | 2003-04-07 |
Family
ID=23305958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95937641T DK0789583T3 (da) | 1994-11-03 | 1995-10-25 | Fremgangsmåder og kits som anvender makrofagstimulerende protein |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5696086A (da) |
| EP (1) | EP0789583B1 (da) |
| JP (1) | JP3769691B2 (da) |
| AT (1) | ATE229813T1 (da) |
| CA (1) | CA2203528C (da) |
| DE (1) | DE69529229T2 (da) |
| DK (1) | DK0789583T3 (da) |
| WO (1) | WO1996014082A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948892A (en) * | 1996-12-16 | 1999-09-07 | Amgen Inc. | Analogs of macrophage stimulating protein |
| IT1292017B1 (it) * | 1997-05-28 | 1999-01-25 | Dompe Spa | Composizioni farmaceutiche contenenti la proteina stimolante i macrofagi per il trattamento di patologie del sistema nervoso |
| US6979442B1 (en) | 1998-08-17 | 2005-12-27 | Pfizer Inc. | Stabilized protein compositions |
| US7235523B2 (en) * | 2001-04-13 | 2007-06-26 | Children's Hospital Medical Center | Methods for the treatment of hepatic disorders |
| KR20150088870A (ko) * | 2012-11-30 | 2015-08-03 | 제넨테크, 인크. | Ron 조성물 및 그의 사용 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| IE81149B1 (en) * | 1987-02-12 | 2000-05-03 | Genentech Inc | Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
| IL92937A0 (en) * | 1989-01-31 | 1990-09-17 | Us Health | Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it |
| US5362716A (en) * | 1989-12-27 | 1994-11-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
| US5219991A (en) * | 1990-09-21 | 1993-06-15 | The United States Of America As Represented By The Department Of Health And Human Services | Macrophage stimulating protein |
| US5227158A (en) * | 1991-06-10 | 1993-07-13 | Genentech, Inc. | Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon |
| US5328837A (en) * | 1992-05-18 | 1994-07-12 | Genentech, Inc. | Hepatocyte growth factor protease domain variants |
| US5316921A (en) * | 1992-05-18 | 1994-05-31 | Genentech, Inc. | Single-chain hepatocyte growth factor variants |
| US5352680A (en) * | 1992-07-15 | 1994-10-04 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists to block opioid agonist tolerance and dependence |
| IL107366A (en) * | 1992-10-23 | 2003-03-12 | Chugai Pharmaceutical Co Ltd | Genes coding for megakaryocyte potentiator |
| JP3682984B2 (ja) * | 1993-10-06 | 2005-08-17 | テルモ株式会社 | 巨核球増加剤および血小板増加剤 |
| US5547931A (en) * | 1994-02-23 | 1996-08-20 | Immtech International Inc. | Methods of stimulatory thrombocytopoiesis using modified C-reactive protein |
-
1994
- 1994-11-03 US US08/334,177 patent/US5696086A/en not_active Expired - Lifetime
-
1995
- 1995-10-25 DK DK95937641T patent/DK0789583T3/da active
- 1995-10-25 CA CA2203528A patent/CA2203528C/en not_active Expired - Lifetime
- 1995-10-25 DE DE69529229T patent/DE69529229T2/de not_active Expired - Lifetime
- 1995-10-25 AT AT95937641T patent/ATE229813T1/de active
- 1995-10-25 WO PCT/US1995/013830 patent/WO1996014082A1/en not_active Ceased
- 1995-10-25 EP EP95937641A patent/EP0789583B1/en not_active Expired - Lifetime
- 1995-10-25 JP JP51535496A patent/JP3769691B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5696086A (en) | 1997-12-09 |
| EP0789583A1 (en) | 1997-08-20 |
| ATE229813T1 (de) | 2003-01-15 |
| WO1996014082A1 (en) | 1996-05-17 |
| JP3769691B2 (ja) | 2006-04-26 |
| MX9703134A (es) | 1998-10-31 |
| CA2203528C (en) | 2010-04-13 |
| DE69529229D1 (de) | 2003-01-30 |
| EP0789583B1 (en) | 2002-12-18 |
| JPH10509446A (ja) | 1998-09-14 |
| CA2203528A1 (en) | 1996-05-17 |
| DE69529229T2 (de) | 2003-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT76970A (hu) | Készítmény az érrendszer specifikus koagulálásához | |
| ATE185602T1 (de) | Verändertes menschliches il-6 | |
| GR3007096T3 (da) | ||
| DE3883985D1 (de) | Ärztliches instrument und dessen herstellung. | |
| DK0922102T3 (da) | Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf | |
| DK1053256T3 (da) | Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf | |
| DE69429524D1 (de) | Aminocyclohexylester und ihre anwendung | |
| GEP20002180B (en) | Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation | |
| IL159527A0 (en) | Human dr4 antibodies and uses thereof | |
| ES2151607T3 (es) | Factor 12 de crecimiento y de diferenciacion. | |
| GR3006073T3 (da) | ||
| ATE35416T1 (de) | Derivate des glycerophosphocholins und glycerophosphoethanolamins, ihre herstellung und verwendung. | |
| ATE82127T1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
| DE69420251D1 (de) | Löslicher Interferon-Rezeptor, seine Herstellung und Anwendung | |
| DK0789583T3 (da) | Fremgangsmåder og kits som anvender makrofagstimulerende protein | |
| FI916118A0 (fi) | 2-aryl-5-(trifluormetyl)-2-pyrrolin- foereningar och foerfarande foer framstaellning av insekticida 2-aryl-1-(alkoximetyl)-4-halogen-5-(trifluormetyl)pyrroler. | |
| ATE128714T1 (de) | Erythromycinderivate. | |
| ES2142490T3 (es) | Ciclopeptolidos. | |
| FI922428A0 (fi) | Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| IL131478A0 (en) | Methods for treatment of scar tissue | |
| GR3005231T3 (da) | ||
| SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| DE69023331D1 (de) | Behandeltes hämoglobin und dessen herstellung. | |
| MX9803272A (es) | N-oxido de lubelozol. | |
| GB9723824D0 (en) | Cytostatic agents |